Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents.
D000293:Adolescent; D000367:Age Factors; D000914:Antibodies, Viral / Q000032:analysis; D002140:California; D002648:Child; D002675:Child, Preschool; D016001:Confidence Intervals; D015925:Cryopreservation; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007109:Immunity / Q000502:physiology*; D007223:Infant; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control*; D008297:Male; D011336:Probability; D018570:Risk Assessment; D012449:Safety; D012737:Sex Factors; D014611:Vaccination / Q000379:methods*; D014613:Vaccines, Attenuated / Q000008:administration & dosage
D000914:Antibodies, Viral; D007252:Influenza Vaccines; D014613:Vaccines, Attenuated